The long-predicted road to a collective mental health crisis accelerated during the COVID-19 pandemic, with studies indicating that the prevalence of depression symptoms in the U.S. grew three-fold.1 The pandemic shined a harsh spotlight on the mental health symptoms plaguing every generation, but anxiety, depression, and mental trauma have been on the rise for years. Despite the writing on the wall, the mental healthcare landscape has lagged behind our declining mental wellness.
The volume of people seeking mental health support online grew 500% from 2019-2021, and yet, the industry is still largely anchored by a decades-old model prioritizing a combined application of pharmacology and psychotherapy.2 While medication and talk therapy has worked —and can work—for many patients, it doesn’t work for everyone.
30% of depression cases are treatment-resistant and 50% of patients experience major side effects from traditional medications.3 No two people are the exact same, which also means that no two cases of depression, anxiety, or mental trauma are the exact same. It’s time for a new approach—one that prioritizes integrating the latest advancements in research and technology with patient-centered treatment plans.
Interventional mental health takes a multidisciplinary approach to answer this much needed call.
Hudson Mind developed its interventional mental health program under the combined direction of leading psychiatrists, pain management specialists, neurologists, and anesthesiologists.
Anchored by cutting-edge treatments that have evolved from the latest neuroscience research, our interventional approach allows us to bring precision medicine to mental healthcare. Each of our founding interventional treatments—ketamine IV therapy, Dual Sympathetic Blocks, Transcranial Magnetic Stimulation— catalyzes transformative responses in the brain or body, making it possible to break depressive patterns, form new neural connections, and calm an agitated nervous system.
Although Hudson Mind’s interventional mental health program makes more treatment options available, it does not eschew more traditional talk therapy or pharmacology. Rather, we recognize that both interventional treatments and conventional therapies are at their most powerful when working in tandem.
With minimally invasive interventions targeting the debilitating symptoms of depression, anxiety, and PTSD, patients can experience breakthroughs that open doors for psychotherapists to explore the roots of trauma and depression, and introduce new cognitive patterns.
Navigating life with symptoms of depression, anxiety, and PTSD is already taxing, and trying to improve those symptoms in a system with finite and impersonal options can feel endlessly frustrating. We cannot seriously address the growing mental health crisis with limited treatment options that leave at least 30% of people behind.
The goal of intervening with data-backed treatments and integrated, personalized psychiatric care is to bring new hope—and lasting relief—to people who may have felt confined or overlooked by a stagnant system.
Ready to learn more about our interventional treatments and integrated approach to psychiatric care? Call 646-906-9703 to schedule your consultation today.
References:
1.Catherine K. Ettman, BA. “Prevalence of Depression Symptoms in US Adults before and during the COVID-19 Pandemic.” JAMA Network Open, JAMA Network, 2 Sept. 2020, https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2770146.
2. “Mental Health and Covid-19: Two Years after the Pandemic, Mental Health Concerns Continue to Increase.” Mental Health America, https://mhanational.org/mental-health-and-covid-19-two-years-after-pandemic.
3. Zhdanava M, Pilon D, Ghelerter I, Chow W, Joshi K, Lefebvre P, Sheehan JJ. The Prevalence and National Burden of Treatment-Resistant Depression and Major Depressive Disorder in the United States. J Clin Psychiatry. 2021 Mar 16;82(2):20m13699. doi: 10.4088/JCP.20m13699. PMID: 33989464)
